| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $31.35B | +18.3% |
| Cost of Revenue | $8.36B | +19.0% |
| Gross Profit | $22.99B | +18.1% |
| R&D Expense | $5.05B | +13.2% |
| SG&A Expense | $2.55B | -1.7% |
| Operating Income | $1.03B | +88.0% |
| Interest Expense | $287.0M | +32.9% |
| Pre-tax Income | $660.0M | -56.9% |
| Income Tax | $452.0M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.02B | +28.4% |
| Accounts Receivable | $10.76B | +10.4% |
| Current Assets | $26.39B | +15.5% |
| Total Assets | $98.85B | +3.8% |
| Current Liabilities | $25.89B | +18.8% |
| Long-term Debt | $10.60B | +0.0% |
| Total Liabilities | $40.49B | +9.2% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.11B | +18.5% |
| Capital Expenditures | $798.0M | +11.3% |
| Investing Cash Flow | -$1.99B | +86.3% |
| Financing Cash Flow | -$3.56B | -145.4% |
| Free Cash Flow | $6.31B | +19.5% |
| +413.6% |
| Net Income | $208.0M | -85.6% |
| EPS (Basic) | $0.21 | -86.1% |
| EPS (Diluted) | $0.21 | -85.8% |
| Stockholders' Equity |
| $58.36B |
| +0.4% |